Akanda (AKAN) Current Assets (2020 - 2025)
Akanda's (AKAN) quarterly Current Assets came in at $3.6 million in Q4 2025, down 28.75% year-on-year from $5.1 million in Q4 2024, and up 0.98% quarter-over-quarter from $3.6 million in Q2 2025.
Akanda (AKAN) Current Assets (2020 - 2025) Analysis & Trends
Akanda's Current Assets history runs 6 years deep, the most recent figure standing at $3.6 million for Q4 2025.
- On a quarterly basis, Current Assets fell 28.75% year-over-year to $3.6 million in Q4 2025; TTM through Dec 2025 was $3.6 million, a 28.75% decrease from a year earlier, with the FY2025 full-year figure at $3.6 million, down 28.75% from the prior year.
- Current Assets rose to $3.6 million in Q4 2025 per AKAN's latest filing, from $3.6 million in the prior quarter.
- Across five years, Current Assets topped out at $7.6 million in Q2 2024 and bottomed at $1.8 million in Q4 2023.
- The 5-year median for Current Assets is $3.8 million (2022), against an average of $4.4 million.
- Across the five-year window, Current Assets jumped 3019.34% in 2021 and tumbled 53.26% in 2023, its largest moves.
- Year by year, Current Assets stood at $4.0 million in 2021, then declined by 4.0% to $3.8 million in 2022, then sank by 52.74% to $1.8 million in 2023, then jumped by 179.95% to $5.1 million in 2024, then decreased by 28.75% to $3.6 million in 2025.
- Per Business Quant, the three latest AKAN Current Assets figures stand at $3.6 million (Q4 2025), $3.6 million (Q2 2025), and $5.1 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Akanda | 556,353.85 | 556,353.85 | - | 3.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.60 Mn |
| Jun 30, 2025 | 3.57 Mn |
| Dec 31, 2024 | 5.06 Mn |
| Jun 30, 2024 | 7.61 Mn |
| Dec 31, 2023 | 1.81 Mn |
| Jun 30, 2023 | 3.25 Mn |
| Dec 31, 2022 | 3.82 Mn |
| Jun 30, 2022 | 6.94 Mn |
| Dec 31, 2021 | 3.98 Mn |
| Dec 31, 2020 | 127,600.00 |